Apparently, a Class Action lawsuit has recently been filed against Johnson & Johnson as the manufacturer did not warn consumers about the risk of developing renal failure due to taking levaquin, an expensive drug used to cure urinary tract infections. The lawsuit claims that over two million individuals became seriously ill from taking Levaquin and one died as a result. It is important for the public to become aware of such dangerous drugs, which may be easily overlooked or taken lightly by doctors. This negligence on the part of Johnson & Johnson has caused great harm to many millions of people and may result in huge financial losses to them.

It is very difficult to determine whether or not a patient has developed any side effects from the antibiotic levaquin class action lawsuit. Most doctors rely on patients’ reports and other medical records to make a diagnosis and prescribe a course of treatment. However, this process is fraught with problems. Most patients who report developing side effects often cannot accurately disclose exactly what they ate or drank. It takes a professional to properly assess these cases and to make a proper ruling on whether or not a particular patient was exposed to harmful antibiotic levaquin dose.

One of the most common side effects reported with taking the antibiotic levaquin class action lawsuit is a high fever. Many patients report experiencing a high temperature of up to 102 degrees Fahrenheit. Some even experienced heat exhaustion while trying to sleep at night. Others became so dehydrated that they were unable to even drink water. In extremely extreme cases, some even developed shock and coma.

This high fever is accompanied by many other symptoms such as chills, sweating, nausea, vomiting, diarrhea, and lightheadedness. At one point, some patients even lost consciousness due to dizziness, fainting, and confusion. When taken in excessive amounts, antibiotic levaquin class action lawsuit flagyl lawsuit can lead to severe and even life-threatening conditions.

The antibiotic levaquin 500 mg dose was eventually pulled from the market, but the manufacturer managed to extract the active ingredient, yohimbe, from another drug, called carbapira. This drug was then sold as a dietary supplement. It would seem that the FDA was not entirely concerned about this situation because in the past, dietary supplements have not always been approved for long term use. In fact, when the European Medicines Agency (EMA) performed a study to determine the safety and effectiveness of carbapira, they did ban its use in children under the age of twelve. However, this was overturned by the FDA because the agency stated that the FDA had not performed adequate studies to show the dangers of the combination of the antibiotic levaquin with the new carbapira drug.

Recently, there has been yet another tragic case in which the use of an antibiotic was misused, resulting in death. A Florida boy developed organ failure due to consumption of unsupervised antibiotics. His parents were trying to treat him with antibiotic levaquin class action lawsuit Flagyl, which was supposed to treat this condition. The FDA did not approve this drug for use in children, and the courts have not found it dangerous enough to ban the drug. The death of this boy is another reminder of how important it is to exercise caution when using any antibiotic.

Leave a Reply

Your email address will not be published. Required fields are marked *